Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has moved to finalize its purchase of CIS bio International, the company reported.
IBA will exercise its option to buy 80.1% of the indirect interest in CIS bio held by the Institut National des Radioéléments (IRE) of Fleurus, Belgium. The purchase price will be 20 million euros ($31 million); IBA will pay 50% in cash and 50% in stock.
The cash payment will be used to start projects useful to the development of IRE, CIS bio, and IBA, the company said.
Copyright © 2008 AuntMinnie.com